awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47590210-6D41F863-C5BA-4CB0-98E5-DE4259EC4C26
Q47590210-6D41F863-C5BA-4CB0-98E5-DE4259EC4C26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47590210-6D41F863-C5BA-4CB0-98E5-DE4259EC4C26
Advances in management of melanoma.
P2860
Q47590210-6D41F863-C5BA-4CB0-98E5-DE4259EC4C26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47590210-6D41F863-C5BA-4CB0-98E5-DE4259EC4C26
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c147074279b0db626068dbc3eb82dcd317053b1e
P2860
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.